Theralink Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb '26 Feb 17, 2026	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Dec '19 Dec 31, 2019
Market Capitalization	0	6	22	256	0	0
Market Cap Growth	-99.92%	-74.29%	-91.60%	58077.31%	588.91%	-62.89%
Enterprise Value	-	18	27	259	4	4
Last Close Price	0.00	0.00	0.00	0.05	0.32	0.10
PS Ratio	0.01	9.12	37.91	506.74	2.43	-
PB Ratio	0.00	-0.14	-5.66	-131.70	0.26	0.00
EV/Sales Ratio	-	29.70	48.07	511.41	24.63	-
Debt / Equity Ratio	-0.42	-0.52	-1.15	-0.25	0.23	-0.24
Net Debt / Equity Ratio	-0.41	-0.49	-1.05	-0.08	-0.83	-0.24
Net Debt / EBITDA Ratio	-3.16	-2.20	-0.35	-0.03	0.43	-2.17
Net Debt / FCF Ratio	-4.64	-3.16	-0.72	-0.03	0.35	-3.27
Asset Turnover	0.25	0.22	0.27	0.21	0.08	-
Inventory Turnover	-	-	-	3.50	-	-
Quick Ratio	0.00	0.03	0.12	0.11	1.52	0.00
Current Ratio	0.00	0.03	0.19	0.19	1.74	0.00
Return on Equity (ROE)	-	-	-	-	-598.14%	-
Return on Assets (ROA)	-191.54%	-200.52%	-343.36%	-143.91%	-97.62%	-689.15%
Return on Capital Employed (ROCE)	13.80%	23.60%	1358.50%	335.80%	-167.40%	11.10%
Earnings Yield	-219440.68%	-558.26%	-59.18%	-2.14%	-719.87%	-14708.01%
FCF Yield	-83184.83%	-107.26%	-25.64%	-1.92%	-908.80%	-1832.01%
Buyback Yield / Dilution	-2.01%	-4.60%	-9.53%	-6242.72%	-17008.05%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.